A ngiopoietin-1 (Ang1) is a recently identified ligand of the endothelium-specific tyrosine kinase receptor Tie-2. 1 It is involved in the angiogenic phase of embryonic vascular development with major defects in the interaction of endothelial cells (ECs), with the surrounding mesenchymal cells and extracellular matrix evident in Ang1 knockout mice. 2 As a result, the vessels are poorly formed, with a lack of branching and remodeling, and are ectatic and leaky. Tie-2 knockout mice have a similar phenotype with additional venous malformation brought about by a disruption of the endothelial-smooth muscle cell interactions. 3 Although these observations have shown that, in development, Ang1 is critical for the stabilization of the interaction of ECs with their surrounding matrix, little is known of how the integrity of mature vessels, and in particular that of the endothelial monolayer, is maintained. Two recent publications have suggested that Ang1 is involved in mature blood vessel control. Firstly, mice transgenic for Ang1 have leakage-resistant blood vessels, 4 and secondly, Ang1, delivered by an adenovirus expression system, inhibited the tissue edema induced by vascular endothelial growth factor (VEGF) and mustard oil, 2 powerful stimulators of vascular leak. 5 Junctions between ECs give the structural basis for the regulation of the passage of plasma proteins or leukocytes into the tissues. 6 Two junctional structures involved in this regulation include the tight junctions 7 and the adherence junctions, which are altered by agents that induce EC permeability or which mediate leukocyte transmigration. 8 -13 Junctional proteins also serve to signal neighboring ECs to maintain their quiescent and anti-inflammatory phenotype. In particular, as endothelial junctions are established, platelet EC adhesion molecule-1 (PECAM-1) rapidly moves to these junctions, 14 suppresses the expression of adhesion molecules such as E-selectin, 15 and prevents EC apoptosis. 16 We show here that Ang1 inhibits EC permeability in vitro and suggest that a likely mechanism is through the regulation of the junctional complexes, PECAM-1 and vascular endothelial (VE) cadherin.
Materials and Methods

Cells
Human umbilical vein ECs were grown and used as described. 15 For VEGF-induced permeability, human umbilical artery ECs 17 were used because they more consistently responded to VEGF 165 .
Reagents
Ang1 used is as described. 18 Anti-VE cadherin and PECAM-1 antibodies have been described. 15 
PECAM-1 Localization
Cells were fixed and stained for PECAM-1 as described. 15 Images were captured using a Bio-Rad laser scanning confocal microscope (MR600). Images under comparison were subjected to equivalent amounts of contrast enhancement. At least 20 fields were analyzed for PECAM localization in each group. These were consecutive fields within the one well and contained Ϸ100 to 400 cells in total.
E-selectin expression was analyzed as described. 15 The endothelial permeability assay was performed essentially as described. 19 The neutrophil transendothelial cell migration assay was performed and quantified by an MTT colorimetric assay. 20, 21 
Immunoprecipitation
Human umbilical vein EC monolayers, confluent for at least 24 hours, were treated with control or Ang1. The lysis, extraction, and analysis were performed as described. 9 An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Ang1 Regulates PECAM-1 Localization to Cell Junctions
ECs plated at low density initially attach to the matrix, flatten, and establish contacts with neighboring cells. Pretreatment of cells with Ang1 did not change the number of cells that adhered to the matrix nor the initial single-cell morphology (not shown); however, it resulted in an enhanced PECAM-1 localization to the junctions ( Figures 1A and 1B) , suggesting that these junctions were forming more rapidly. At 45 minutes after cell plating, Ang1 did not affect the number of cell aggregates, the number of cells in each aggregate, or the expression of cell-surface PECAM-1 or VE cadherin (see online Table 1 ; online-only data supplement available at http://www.circresaha.org). However, the number of cell contacts that showed PECAM-1 localization increased from 55Ϯ5% to 75Ϯ5% (nϭ2 experiments) between control and Ang1 treatment, respectively, and the percentage of cells with the most intense junctional staining of PECAM-1 increased from 1% to 27% (see online Figure 1 ; online-only data supplement available at http://www.circresaha.org). The changes were specific for Ang1, given that the other angiogenic factors, VEGF and basic fibroblast growth factor, had no such effects (not shown). These data suggest that Ang1 may affect cell junctions, and therefore we extended our analysis to assays that involve junctional regulation.
Ang1 Inhibits E-Selectin Expression
PECAM-1 has been proposed as an important mechanosensing molecule in ECs, 22, 23 mediating inhibition of proliferation, 24 migration, 25 apoptosis, 16 and expression of adhesion molecules. 15 As such, the consequence of the enhanced PECAM-1-PECAM-1 engagement mediated by Ang1 should be to mature the cells into a quiescent, nonproliferative, noninflammatory phenotype. E-selectin expression is involved in inflammation, 15 proliferation, 26 and angiogenesis, 27 and thus its presence can be considered a marker of an activated endothelium. Cells plated at low density express low but significant levels of E-selectin. The induction under this situation is cytokine independent but dependent on integrin attachment and the loss of PECAM-PECAM interaction. 15 Treatment with Ang1 inhibited the E-selectin expression (Figures 2A and 2B ) in a dose-dependent manner (see online Figure 2 ; online-only data supplement available at http://www.circresaha.org). Ang1 had no effect on tumor necrosis factor-␣ (TNF-␣)-induced E-selectin expression (see online Table 2 , groups a through d; online-only data supplement available at http://www.circresaha.org).
Ang1 Inhibits EC Permeability
Ang1 treatment of EC monolayers inhibited their basal permeability ( Figure 3A ) in a dose-dependent manner. More strikingly, Ang1 inhibited the permeability induced by 2 classic EC permeability-inducing agents, thrombin and VEGF ( Figures 3B and 3C ) by 70% and 100%, respectively. The phosphatidylinositol 3-kinase (PI3K) pathway, although implicated in Ang1-mediated EC survival, 28, 29 does not appear to be involved in the regulation of permeability. The PI3K-specific inhibitor LY294002 had no effect on Ang1-induced inhibition of permeability (online Figure 3 ; onlineonly data supplement available at http://www.circresaha.org), although it reversed, in parallel experiments, the protective effect of Ang1 on EC survival (not shown). This result suggests that an alternate signaling pathway to PI3K is used by the Tie2 receptor to mediate changes in cell junctions.
The transmigration of leukocytes induced by cytokines such as TNF-␣ is also regulated by endothelial junctions. 30 -33 Ang1 pretreatment of ECs abolished TNF-␣-induced transmigration ( Figure 3D ). The Ang1 effect was not mediated through changes in TNF-␣ signaling, because maximum inhibition of transmigration was seen when Ang1 was added at the end of the stimulation period 15 minutes before polymorphonuclear neutrophil addition. Under these conditions, Ang1 had no effect on the level of TNF-␣-induced E-selectin expression (see online Table 2 , groups e and f; online-only data supplement available at http://www.circresaha.org). Furthermore, Ang1 treatment of the neutrophils did not alter their capacity to transmigrate (not shown).
The inhibitory effect of Ang1 on E-selectin expression, permeability, and transmigration was mediated through the Tie2 receptor, because the Tie2 Fc-soluble protein abolished these responses (see online Figures 4a through 4c; onlineonly data supplement available at http://www.circresaha.org).
Ang1 Alters VE Cadherin and PECAM-1 Phosphorylation
PECAM-1, VE cadherin, and its associated signaling molecules the catenins have been implicated in the regulation of EC junctions. Changes in phosphorylation of PECAM-1 and association of the catenins with VE cadherin are seen during histamine-, thrombin-, and VEGF-induced permeability and during polymorphonuclear neutrophil transmigration. 8 -12 Ang1 treatment for 10 minutes induced a decrease in the basal phosphorylation of VE cadherin, which returned to normal levels by 30 minutes (Figure 4A) . In 2 experiments performed, the decrease was 33% and 45% normalized to VE cadherin content. Although no significant change in phosphorylation of ␤-catenin was evident, an increase in the amount of ␤-catenin associated with VE cadherin was observed. Ang1 also induced a significant decrease in basal PECAM-1 phosphorylation ( Figure 4B ). In 2 experiments performed, the decrease was 48% and 51% normalized to PECAM-1 content. The changes in phosphorylation of PECAM-1 and VE cadherin and increase in the association of ␤-catenin with VE cadherin are consistent with an increase in cell-cell interaction. 6, 8, 9, 34 
Discussion
Enhanced interaction of ECs with their supporting structures has been the chief explanation for the angiogenic effects of Ang1 both in development and in vitro. 2, 18 The results presented here suggest that the additional mechanism of stabilization of cell-cell interactions may also be operative. Indeed, this multilevel effect of Ang1 compounds the antiproliferative and antiapoptotic effects of cell-cell and cellmatrix interactions. 16, [35] [36] [37] [38] [39] [40] Our in vitro findings highlight a potentially critical role for Ang1 in maintaining the integrity of endothelial monolayers in mature animals. To our knowledge, this is the first agent that, by an action on ECs, prevents the acute leakiness of blood vessels that is involved in the generation of swelling or edema seen in inflammatory or allergic reactions. Moreover, the degree of inhibition of between 70% and 100% suggests that this is a potentially potent and physiological mechanism. The effects on inhibition of permeability and transmigration, as well as on the prevention of cytokine-independent expression of adhesion proteins, are consistent with its effect on cellular junctions, and this is supported by the alteration in 2 important molecules involved in EC integrity, namely PECAM-1 and VE cadherin. However, other mechanisms of action cannot be ruled out. Nevertheless, these findings suggest a role for Ang1 from embryogenesis to adulthood and open the possibility of its therapeutic use in inflammatory diseases.
